Estimated reading time: 0 minutes, 37 seconds

Thomson Reuters, Zynx Health Partner on Drug, Disease Info

Thomson Reuters and Zynx Health said the Thomson Reuters Micromedex will be integrated into ZynxOrder evidence-based order sets.

This move pushes Micromedex clinical reference information to the point of care, giving physicians access to comprehensive drug information and disease protocols from their ZynxOrder evidence-based order set. Thomson Reuters will partner with Zynx Health as its source for order set solutions, and Zynx Health will offer Micromedex content as a preferred choice for clinical reference content. Joint customers will have contextual links from their ZynxOrder order sets into the Micromedex content.

The agreement brings Zynx Health’s experience providing evidence-based and experience-based clinical decision support solutions to more than 1,700 hospitals together with Thomson Reuters’ market leadership in providing Micromedex evidence-based clinical reference information to more than 3,500 hospitals.

Read 23376 times
Rate this item
(0 votes)

Visit other PMG Sites:

PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.